Springworks Therapeutics

Springworks Therapeutics company information, Employees & Contact Information

SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. Founded in 2017, SpringWorks has a diversified targeted oncology pipeline spanning solid tumors and hematological cancers, including clinical trials in rare tumor types and highly prevalent, genetically defined cancers.

Company Details

Employees
418
Founded
-
Address
100 Washington Blvd, Stamford,connecticut 06902,united States
Phone
203-883-9490
Email
in****@****stx.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Stamford, Connecticut
Looking for a particular Springworks Therapeutics employee's phone or email?

Springworks Therapeutics Questions

News

SpringWorks Therapeutics Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire

SpringWorks Therapeutics Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates at 43rd Annual J.P. Morgan Healthcare Conference GlobeNewswire

SpringWorks Therapeutics to Participate in the Jefferies London Healthcare Conference - FinancialContent

SpringWorks Therapeutics to Participate in the Jefferies London Healthcare Conference FinancialContent

Allogene Therapeutics and SpringWorks Therapeutics Announce Dosing of First Patient in Phase 1 Study Evaluating ALLO-715 in Combination with Nirogacestat in Patients with Relapsed or Refractory Multiple Myeloma - Allogene

Allogene Therapeutics and SpringWorks Therapeutics Announce Dosing of First Patient in Phase 1 Study Evaluating ALLO-715 in Combination with Nirogacestat in Patients with Relapsed or Refractory Multiple Myeloma Allogene

SpringWorks Therapeutics Highlights Nirogacestat Clinical Data at the 2022 ASCO Annual Meeting - Yahoo Finance

SpringWorks Therapeutics Highlights Nirogacestat Clinical Data at the 2022 ASCO Annual Meeting Yahoo Finance

SpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief Scientific Officer - citybiz

SpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief Scientific Officer citybiz

Nirogacestat Gets Fast-Tracked for the Treatment of Desmoid Tumors - Medical Professionals Reference

Nirogacestat Gets Fast-Tracked for the Treatment of Desmoid Tumors Medical Professionals Reference

FDA Grants Priority Review to SpringWorks Therapeutics’ New - GlobeNewswire

FDA Grants Priority Review to SpringWorks Therapeutics’ New GlobeNewswire

SpringWorks Therapeutics Announces European Medicines - GlobeNewswire

SpringWorks Therapeutics Announces European Medicines GlobeNewswire

Top Springworks Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant